The device is a continuation of NovaBone’s portfolio of bioactive bone grafts. It is designed as a rapidly-absorbable binder, and the open structure of the porous component allows for rapid vascularization and mineralization.
Read the news release about NovaBone.
Related Articles on Orthopedic Devices:
TranS1 Revenues Continue to Slide in 2Q With 26% Decrease
MedShape’s Ankle Fusion Device Receives FDA 510(k) Clearance
Integra LifeSciences Launces Anterior Cervical Fixation System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.